Just before the outbreak, the NIAID, headed by Dr. Fauci, funded a grant for monkeypox treatment research, especially tecovirimat.
Shortly before the virus spread in a global outbreak, Anthony Fauci's National Institutes of Health organization was sponsoring research to find treatments for monkeypox.
The National Institute of Allergy and Infectious Diseases (NIAID), which Fauci heads, has previously been criticized for sponsoring bat coronavirus research at the Wuhan Institute of Virology, which many public health professionals and intelligence officials believe is the source of COVID-19.
Shortly before the viral disease spread in a global outbreak, the NIAID financed research into potential cures for monkeypox. The NIAID grant comes at a time when pharmaceutical companies like Pfizer and Johnson & Johnson are reaping record profits as a result of the COVID-19 outbreak.
"A randomized, placebo-controlled trial of the safety and efficacy of tecovirimat for the treatm...